3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with domperidone in 1 studies
| Studies (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Trials (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Recent Studies (post-2010) (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Studies (domperidone) | Trials (domperidone) | Recent Studies (post-2010) (domperidone) |
|---|---|---|---|---|---|
| 68 | 2 | 18 | 1,977 | 275 | 468 |
| Protein | Taxonomy | 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (IC50) | domperidone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 7.9 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.332 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.614 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.74 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0026 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.125 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.011 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.614 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.065 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.037 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.332 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.055 | |
| Histamine H1 receptor | Homo sapiens (human) | 1.344 | |
| Mu-type opioid receptor | Homo sapiens (human) | 4.218 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.018 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 6.994 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.6 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0052 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1447 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bubl, B; Feuerstein, TJ; Hubbe, U; Huethe, F; Jackisch, R; Löffler, M; McIntosh, JM | 1 |
1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and domperidone
| Article | Year |
|---|---|
Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adolescent; Adult; Aged; Alkaloids; Analysis of Variance; Animals; Autoreceptors; Azocines; Calcium; Child; Child, Preschool; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Feedback; Female; Fluvoxamine; Humans; In Vitro Techniques; Isoxazoles; Male; Maprotiline; Mice; Middle Aged; Neocortex; Nicotine; Nicotinic Antagonists; Potassium; Pyrrolidines; Quinolizines; Rats; Receptors, Nicotinic; Sulpiride; Time Factors; Tritium | 2006 |